Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 35% ± 20% | |
peripheral blood | 11 studies | 23% ± 6% | |
lung | 11 studies | 22% ± 11% | |
eye | 8 studies | 23% ± 8% | |
kidney | 4 studies | 19% ± 0% | |
liver | 4 studies | 26% ± 9% | |
intestine | 4 studies | 21% ± 7% | |
adipose | 4 studies | 20% ± 2% | |
pancreas | 3 studies | 29% ± 4% | |
bone marrow | 3 studies | 18% ± 1% | |
heart | 3 studies | 20% ± 1% | |
lymph node | 3 studies | 16% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 467.76 | 1442 / 1445 | 100% | 12.05 | 183 / 183 |
stomach | 100% | 411.96 | 358 / 359 | 100% | 11.68 | 285 / 286 |
ovary | 100% | 272.95 | 180 / 180 | 99% | 8.62 | 424 / 430 |
lung | 99% | 351.51 | 575 / 578 | 98% | 7.82 | 1130 / 1155 |
brain | 99% | 358.73 | 2605 / 2642 | 98% | 10.57 | 691 / 705 |
intestine | 100% | 437.11 | 966 / 966 | 95% | 9.19 | 502 / 527 |
breast | 100% | 399.48 | 459 / 459 | 94% | 6.62 | 1046 / 1118 |
pancreas | 100% | 383.84 | 328 / 328 | 93% | 5.23 | 165 / 178 |
prostate | 100% | 320.18 | 244 / 245 | 91% | 6.68 | 458 / 502 |
thymus | 100% | 328.15 | 651 / 653 | 87% | 5.38 | 526 / 605 |
bladder | 100% | 401.24 | 21 / 21 | 87% | 5.47 | 436 / 504 |
skin | 100% | 490.21 | 1806 / 1809 | 87% | 4.65 | 409 / 472 |
kidney | 100% | 244.83 | 89 / 89 | 82% | 4.50 | 740 / 901 |
uterus | 100% | 337.42 | 170 / 170 | 81% | 5.22 | 373 / 459 |
adrenal gland | 98% | 348.07 | 253 / 258 | 69% | 3.30 | 159 / 230 |
liver | 79% | 126.85 | 178 / 226 | 51% | 2.21 | 208 / 406 |
adipose | 100% | 452.09 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 669.23 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 213.17 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 470.90 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 363.40 | 888 / 929 | 0% | 0 | 0 / 0 |
heart | 91% | 311.20 | 782 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 5.93 | 39 / 45 |
lymph node | 0% | 0 | 0 / 0 | 59% | 3.26 | 17 / 29 |
eye | 0% | 0 | 0 / 0 | 57% | 2.11 | 46 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045648 | Biological process | positive regulation of erythrocyte differentiation |
GO_2000369 | Biological process | regulation of clathrin-dependent endocytosis |
GO_0005737 | Cellular component | cytoplasm |
GO_0005886 | Cellular component | plasma membrane |
GO_0030276 | Molecular function | clathrin binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | SMAP1 |
Protein name | Small ArfGAP 1 Alternative protein SMAP1 Stromal membrane-associated protein 1 |
Synonyms | |
Description | FUNCTION: GTPase activating protein that acts on ARF6. Plays a role in clathrin-dependent endocytosis. May play a role in erythropoiesis (By similarity). . |
Accessions | ENST00000619054.4 ENST00000370452.7 [Q8IYB5-3] A0A087X1X9 ENST00000370455.8 [Q8IYB5-1] ENST00000445046.1 L0R5C9 ENST00000316999.9 [Q8IYB5-2] ENST00000439432.1 H0Y5G0 Q8IYB5 Q5T6I8 |